Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bFGF plus negative pressure wound therapy for chronic nonhealing ulcers
jRCT1090220052Completed
- Sponsor
- Masahiro Tachi
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of trafermin in Chronic cutaneous ulcer, decubitus ulcer, diabetic foot ulcer (DFU) and 3 more (2 arms), sponsored by Masahiro Tachi. Primary endpoint: Wound reduction rate per week. Started Nov 2010; status: completed.
02
Drugs
trafermin
03
Conditions
Chronic cutaneous ulcerdecubitus ulcerdiabetic foot ulcer (DFU)arterial ulcerstasis ulcer
Beyond the preview
Go deeper on jRCT1090220052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220052.